Table 4.
Skin and soft tissue source definitive IV vs. PO comparison
| Variable | IV (N = 33) | PO (N = 83) |
|---|---|---|
| Age (years) [median (IQR)] | 61 (44.5–72.5) | 58 (45–75) |
| Female sex [n (%)] | 17 (51.5) | 34 (41.0) |
| White race [n (%)] | 29 (87.9) | 80 (96.4) |
| Pitt bacteremia score [median (IQR)] | 2 (1–3) | 1 (0–3) |
| Charlson Comorbidity Index [median (IQR)] | 5 (2.5–7) | 3 (1–6) |
| Total duration of therapy (days) [median (IQR)] | 15 (14–18) | 14 (12–17) |
| Length of stay (days) [median (IQR)] | 6 (4–9.5) | 5 (3–6) |
| Ninety-day mortality [n (%)] | 2 (6.1) | 2 (2.4) |
| In-hospital mortality [n (%)] | 1 (3.0) | 0 |
| Adverse events [n (%)] | – | – |
| Clostridioides difficile infection | 0 | 1 (1.2) |
| Occluded PICC line | 0 | – |
| Ninety-day readmission due to clinical failure [n (%)] | 5 (15.2) | 14 (16.9) |
Note. IQR, interquartile range; IV, intravenous; PICC, peripherally inserted central catheter; PO, oral.